TRINITY BIOTECH, PLC

Trinity Biotech plc is a publicly listed clinical diagnostic products manufacturer specializing in blood analyzers, rapid immunoassays, and laboratory consumables. The company develops and markets diagnostic solutions across hematology, infectious disease, and metabolic screening. Key product lines include the Premier Resolution HPLC analyzer for hemoglobin variant and thalassemia detection; Uni-Gold HIV Complete rapid immunoassay for HIV-1/HIV-2 detection in serum, plasma, and whole blood; Bartels FlexTrans transport medium for specimen preservation; and Captia brand diagnostics. Trinity Biotech serves clinical laboratories, blood banks, and point-of-care settings globally. The company holds regulatory approvals including IFCC classification (Gold standard for HbA1c measurement on Premier Hb9210 system) and operates under offshored and outsourced manufacturing models to support supply chain efficiency. As a Nasdaq-listed entity, Trinity Biotech maintains compliance with regulatory and listing requirements, positioning itself as a supplier of high-quality, validated diagnostic instrumentation and consumables for clinical and research applications.